25 May 2013
Keywords: amicus, amigal, gets, od, nod, comp, new
Article | 24 April 2006
New Jersey, USA-based biopharmaceutical company Amicus Therapeutics, a specialist developer of oral drugs for the treatment of human genetic
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 April 2006
1 May 2006
24 May 2013
© 2013 thepharmaletter.com